We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina (MOH) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
In the latest trading session, Molina (MOH - Free Report) closed at $148.16, marking a +0.17% move from the previous day. This move lagged the S&P 500's daily gain of 0.41%. Meanwhile, the Dow gained 0.39%, and the Nasdaq, a tech-heavy index, added 0.57%.
Coming into today, shares of the provider of Medicaid-related services had gained 14.13% in the past month. In that same time, the Medical sector gained 2.28%, while the S&P 500 gained 0.1%.
Wall Street will be looking for positivity from MOH as it approaches its next earnings report date. On that day, MOH is projected to report earnings of $2.56 per share, which would represent year-over-year growth of 13.78%. Our most recent consensus estimate is calling for quarterly revenue of $4.07 billion, down 16.57% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $10.94 per share and revenue of $16.39 billion, which would represent changes of +3.11% and -13.23%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for MOH. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.14% higher. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
In terms of valuation, MOH is currently trading at a Forward P/E ratio of 13.52. Its industry sports an average Forward P/E of 14.29, so we one might conclude that MOH is trading at a discount comparatively.
Also, we should mention that MOH has a PEG ratio of 1.03. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - HMOs stocks are, on average, holding a PEG ratio of 1.02 based on yesterday's closing prices.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 18, which puts it in the top 8% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Molina (MOH) Gains But Lags Market: What You Should Know
In the latest trading session, Molina (MOH - Free Report) closed at $148.16, marking a +0.17% move from the previous day. This move lagged the S&P 500's daily gain of 0.41%. Meanwhile, the Dow gained 0.39%, and the Nasdaq, a tech-heavy index, added 0.57%.
Coming into today, shares of the provider of Medicaid-related services had gained 14.13% in the past month. In that same time, the Medical sector gained 2.28%, while the S&P 500 gained 0.1%.
Wall Street will be looking for positivity from MOH as it approaches its next earnings report date. On that day, MOH is projected to report earnings of $2.56 per share, which would represent year-over-year growth of 13.78%. Our most recent consensus estimate is calling for quarterly revenue of $4.07 billion, down 16.57% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $10.94 per share and revenue of $16.39 billion, which would represent changes of +3.11% and -13.23%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for MOH. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.14% higher. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
In terms of valuation, MOH is currently trading at a Forward P/E ratio of 13.52. Its industry sports an average Forward P/E of 14.29, so we one might conclude that MOH is trading at a discount comparatively.
Also, we should mention that MOH has a PEG ratio of 1.03. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - HMOs stocks are, on average, holding a PEG ratio of 1.02 based on yesterday's closing prices.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 18, which puts it in the top 8% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.